Apoptotic signal of Fas is not mediated by ceramide

Blood

Volumn 91, Issue 8, 1998, Pages 2658-2663

  Hsu, Shu Ching ^b   Wu, Chia Cheng ^b   Luh, Tien Yau ^b   Chou, Chen Kung ^b   Han, Shau Hwa ^b   Lai, Ming Zong ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUCLADESINE; CARBAMIC ACID DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; CERAMIDE; CHELATING AGENT; DNA FRAGMENT; FAS ANTIGEN; FORSKOLIN; FULLERENE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; PROTEIN KINASE; PYRROLIDINE DITHIOCARBAMATE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SECOND MESSENGER; SIGNAL TRANSDUCTION;

EID: 0032523042     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.8.2658.2658_2658_2663     Document Type: Article

References (45)

1. Nagata S: Apoptosis by death factor. Cell 88:355, 1997
2. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81:505, 1995
3. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D: A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 270:7795, 1995
4. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM: Flice, a novel FADD-homologue ICE/CED-3-like protease, is recruited to the CD95(Fas/APO-1) death-inducing signaling complex. Cell 85:817, 1996
5. Boldin MP, Goncharov TM, Goltsev YV, Wallach D: Involvement of MACH, a novel MORT1/FADD-interacting protease in Fas/APO-1- and TNF receptor-induced cell death. Cell 85:803, 1996
6. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, Peter ME: FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 16:2794, 1997
7. Enari M, Talanian RV, Wong WW, Nagata S: Sequential activation of ICE-like and CPP32-like protease during Fas-mediated apoptosis. Nature 380:723, 1996
8. Cifone MG, Maria RD, Roncaioli P, Rippo MR, Azuma M, Lanier LL, Santoni A, Testi R: Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med 179:1547, 1994
9. Cifone MG, Roncaioli P, De Maria R, Camarda G, Santoni A, Giovna R, Testi R: Multiple pathways originate at the Fas/APO-1 (CD95) receptor: Sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphigomyelinase in the propagation of apoptotic signal. EMBO J 14:5859, 1995
10. Gill BM, Nishikata H, Chan G, Delovitch TL, Ochi A: Fas antigen and sphingomyelin-ceramide turnover-mediated signalling: Role in life and death of T lymphocytes. Immunol Rev 142:113, 1994
11. Gulbins E, Bissonnette R, Mahboubi A, Martin S, Nishioka W, Brunner T, Baier G, Baier-Bitterlich G, Byrd C, Lang F, Kolesnick R, Altman A, Green D: Fas-induced apoptosis is mediated by a ceramideinitiated Ras signalling pathway. Immunity 2:341, 1995
12. Tepper CG, Jayadev S, Lin B, Bielawska A, Wolff R, Yonehara S, Hannun A, Seldin MF: Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc Natl Acad Sci USA 92:8443, 1995
13. Obeid LM, Linardic CM, Karolak LA, Hannun YA: Programmed cell death induced by ceramide. Science 259:1769, 1993
14. Kolesnick R, Golde DW: The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77:325, 1994
15. Haimovitz-Friedman A, Kan CC, Ehleiter D, Persaud RS, Mcloughlin M, Fuks Z, Kolesnick RN: Ionization radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med 180:525, 1994
16. Dbaibo GS, Obeid LM, Hannun YA: Tumor necrosis factor-α (TNF-α) signal transduction through ceramide. J Biol Chem 268:17762, 1993
17. Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick R: Ceramide synthetase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals. Cell 82:405, 1995
18. Jaffrezou JP, Levade T, Bettaieb A, Andrieu N, Bezombes C, Maestre N, Vermeersch S, Rousse A, Laurent G: Daunorubicin-induced apoptosis: Triggering of ceramide generation through sphingomyelin hydrolysis. EMBO J 15:2417, 1996
19. Spiegel S, Foster D, Kolesnick R: Signal transduction through lipid second messengers. Curr Opin Cell Biol 8:159, 1996
20. Wright SC, Zheng H, Zhong J: Tumor cell resistance to apoptosis due to a defect in the activation of sphigomyelinase and the 24 kDa apoptotic protease (AP24). FASEB J 10:325, 1996
21. Santana P, Pena LA, Haimovitz-Friedman A, Martin S, Green D, McLoughlin M, Cordon-Cardo C, Schuchman EH, Fuks Z, Kolesnick R: Acid sphinomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 86:189, 1996
22. Cai Z, Bettaieb A, Mahdani NE, Legres LG, Stancou R, Masliah J, Chouaib S: Alteration of the sphingomyelin/ceramide pathway is associated with resistance of human breast carcinoma MCF7 cells to tumor necrosis factor-α-mediated cytotoxicity. J Biol Chem 272:6981, 1997
23. Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z, Kolesnick RN: Requirement for ceramide-initiated SAPK/JNK signaling in stress-induced apoptosis. Nature 380:75, 1996
24. Sillence DJ, Allen D: Evidence against an early signalling role for ceramide in Fas-mediated apoptosis. Biochem J 324:29, 1997
25. Watts JD, Gu M, Polverino AJ, Patterson SD, Aebersold R: Fas-induced apoptosis of T cells occurs independently of ceramide generation. Proc Natl Acad Sci USA 94:7292, 1997
26. Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with receptor of tumor necrosis factor. J Exp Med 169:1747, 1989
27. Dugan LL, Tureysky DM, Du C, Lobner D, Wheeler M, Almli CR, Shen CKF, Luh TY, Choi DW, Lin TS: Carboxyfullerenes as neroprotective agents. Proc Natl Acad Sci USA 94:9434, 1997
28. Ballard DW, Dixon EP, Perfer NJ, Bogerd H, Doeree S, Stein B, Greene WC: The 65-kDa subunit of human NF-KB functions as a potent transcriptional activator and a target for v-Rel-mediated repression. Proc Natl Acad Sci USA 89:1875, 1992
29. Hibl M, Lin A, Smeal T, Minden A, Karin M: Identification of an oncoprotein- and UV-responsive protein kinase that bind and potentiate the c-Jun activation domain. Genes Dev 7:2135, 1993
30. Sanchez I, Hughes RT, Mayer BJ, Yee K, Woodgett JR, Avruch J, Kyriakis MJ, Zon LI: Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature 372:794, 1994
31. Hsueh YP, Liang HE, Ng SY, Lai MZ: CD28 costimulation activates CREB in T lymphocytes. J Immunol 158:85, 1997
32. Ho HY, Lee HH, Lai MZ: Overexpression of mitogen-activated protein kinase kinase kinase reverses cAMP inhibition of NF-kB in T cells. Eur J Immunol 27:222, 1997
33. Hsueh YP, Lai MZ: c-Jun N-terminal kinase but not mitogen-activated protein kinase is sensitive to cAMP in T lymphocytes. J Biol Chem 270:18094, 1995
34. Lee MR, Liou ML, Liou ML, Yang YF, Lai MZ: cAMP analogs prevent activation-induced apoptosis of T cell hybridoma. J Immunol 151:5208, 1993
35. Higuchi M, Singh S, Jaffrezou JP, Aggarwal BB: Acidic sphingo-myelinase-generated ceramide is needed but not sufficient for TNF-induced apoptosis and nuclear factor-KB activation. J Immunol 156: 297, 1996
36. Schulze-Osthoff K, Krammer PH, Droge W: Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J 13:4587, 1994
37. Wilson DJ, Fortner KA, Lynch DH, Mattingly RR, Macara IG, Posada JA, Budd RC: JNK, but not MAPK, activation is associated with Fas-mediated apoptosis in human T cells. Eur J Immunol 26:989, 1996
38. Schulze K, Walczak H, Droge W, Debatin KM, Krammer PH: Cell nucleus and DNA fragmentation are not required for apoptosis. J Cell Biol 127:15, 1994
39. Nakajima H, Golstein P, Henkart PA: The target cell nucleus is not required for cell-mediated granzyme-or Fas-based cytotoxicity. J Exp Med 181:1905, 1995
40. Smyth MJ, Perry DK, Zhang J, Poirier GG, Hannun YA, Obeid LM: prICE: A downstream target for ceramide-induced apoptosis and for inhibitory action of Bcl-2. Biochem J 316:25, 1996
41. Lenczowski JM, Dominguez L, Eder A, King LB, Zacharchuk CM, Aswell JD: Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis. Mol Cell Biol 17:170, 1997
42. Yang X, Khosravi-Far R, Chang HY, Baltimore D: Daxx, a novel fas-binding protein that activates JNK and apoptosis. Cell 88:1067, 1997
43. Beg AA, Baltimore D: An essential role for NF-KB in preventing TNF-α-induced cell death. Science 274:782, 1996
44. Wang CY, Mayo MW, Baldwin AS: TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-KB. Science 274:784, 1996
45. Van Antewerp DJ, Martin SJ, Kafri T, Green DR, Verma IM: Suppression of TNF-α-induced apoptosis by NF-KB. Science 274:784, 1996